Find clinical trials for Lymphoma in Indianapolis, IN
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lymphoma trials near Indianapolis, IN, USA:
focused on patients who have one of two types of cancer: follicular lymphoma (FL) or marginal zone lymphoma (MZL) that has come bac...
Phase 3
Indianapolis, Indiana, United States and 60 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Indianapolis, Indiana, United States and 50 other locations
treatment of advanced classical Hodgkin lymphoma(HL)...
Phase 3
Indianapolis, Indiana, United States and 215 other locations
with various types of blood cancers:relapsed or refractory (R/R) lymphomamultiple myelomanewly diagnosed acute myeloid leukemia (AML).This t...
Phase 1
Indianapolis, Indiana, United States and 61 other locations
is an oral Bcl-2 family protein inhibitor. It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overex...
Phase 2
Indianapolis, Indiana, United States and 9 other locations
the maximum tolerated dose (MTD) of ruxolitinib when given with fixed dose nivolumab in patients with relapsed or refractory classical Hodgkin lymphoma...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 4 other locations
and cyclophosphamide alone in a lymphodepletion regimen prior to ALLO-501A CAR T therapy in adults with relapsed or refractory large B-cell lymphoma...
Phase 2
Indianapolis, Indiana, United States and 10 other locations
is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL).This study will be...
Phase 3
Noblesville, Indiana, United States and 65 other locations
Single arm phase I/II study of ixazomib and romidepsin in relapsed/refractory PTCL. Each cycle is 28 days. Patients will continue to receive therapy...
Phase 1, Phase 2
Indianapolis, Indiana, United States and 6 other locations
1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non-Hodgkin lymphoma...
Phase 1
Indianapolis, Indiana, United States and 8 other locations
Clinical trials
Research sites
Resources
Legal